SCHEMBL5583049

SCHEMBL5583049

Cc1ccc(C(=O)O)c(C(=O)Nc2ccccc2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
HPGD P15428 3/20 0.57
SORT1 Q99523 2/20 0.57
MAPK1 P28482 1/20 0.57
GFER P55789 1/20 0.57
CYP1A2 P05177 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
AVPR2 P30518 1/20 0.56
GPR27 Q9NS67 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX12 P18054 1/20 0.56
MAOB P27338 2/20 0.55
F12 P00748 1/20 0.55
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
MAPT P10636 2/20 0.54
LMNA P02545 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17122454 0.92 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AHPGDSORT1
SCHEMBL11582184 0.87 MEN1 (0.59) ALDH1A1MEN1KMT2AHPGDCYP1A2
SCHEMBL14112955 0.85 HPGD (0.69) ALDH1A1MEN1KMT2AHPGDCYP1A2
SCHEMBL4147334 0.85 GPR27 (0.72) ALDH1A1MEN1KMT2AHPGDTDP1
SCHEMBL12700350 0.84 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AHPGDSORT1
SCHEMBL6285639 0.83 TMPRSS4 (0.67) ALDH1A1MEN1KMT2AHPGDTDP1
SCHEMBL14514566 0.83 PLG (0.67) ALDH1A1MEN1KMT2AHPGDTDP1
SCHEMBL10489747 0.83 NPC1 (0.60) ALDH1A1MEN1KMT2AHPGDMAPK1
SCHEMBL14864556 0.83 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AHPGDMAPK1
SCHEMBL10489953 0.83 ALDH1A1 (0.76) ALDH1A1MEN1KMT2AHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-7115750-B1 Melanin concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173498-A1 Melanin concentrating hormone antagonist MC1R, MCHR1, MCHR2 ALDH1A1 1784/4885MEN1 380/4885KMT2A 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.